InfuSystem Holdings Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
4analysts covering
FY Revenue (est.)
$144.8Mnext fiscal year
FY EPS (est.)
$0.43next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 10 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Patient Services Net Revenue Quarterly22.1M
Device Solutions Net Revenue Quarterly11.6M
Adjusted EBITDA Margin Quarterly18.9%Target: low to mid 20% range
Wound Care Revenue Share of Total Quarterly6.0%
Watch Items
- GE HealthCare Contract Restructuring ImpactTrigger: Annual revenue reduction exceeding $7.1 millionAction: Monitor Device Solutions segment margins to ensure the intended profitability improvements materialize to offset the top-line headwind.
- ERP System Implementation and Cost SavingsTrigger: Failure of ERP-related costs to taper down by year-end 2026Action: Track SG&A expenses and operational efficiency metrics to verify that projected cost savings begin materializing in 2027.
- Oncology RCM Migration to Apollo PlatformTrigger: Delays extending past year-end 2026Action: Review quarterly progress updates on the migration timeline to prevent disruption in oncology billing and collections.
Research as of 20 Jun 2026